KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Other Working Capital Changes (2016 - 2025)

Pacific Biosciences Of California has reported Other Working Capital Changes over the past 16 years, most recently at $38000.0 for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $38000.0 for Q4 2025, down 97.34% from a year ago — trailing twelve months through Dec 2025 was $723000.0 (up 117.48% YoY), and the annual figure for FY2025 was $723000.0, up 134.3%.
  • Other Working Capital Changes for Q4 2025 was $38000.0 at Pacific Biosciences Of California, down from $7.5 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for PACB hit a ceiling of $7.5 million in Q3 2025 and a floor of -$8.1 million in Q2 2025.
  • Median Other Working Capital Changes over the past 5 years was $423000.0 (2023), compared with a mean of $78000.0.
  • Biggest five-year swings in Other Working Capital Changes: surged 1063.79% in 2021 and later crashed 661.7% in 2024.
  • Pacific Biosciences Of California's Other Working Capital Changes stood at $1.0 million in 2021, then soared by 548.97% to $6.6 million in 2022, then tumbled by 158.62% to -$3.9 million in 2023, then skyrocketed by 136.64% to $1.4 million in 2024, then tumbled by 97.34% to $38000.0 in 2025.
  • The last three reported values for Other Working Capital Changes were $38000.0 (Q4 2025), $7.5 million (Q3 2025), and -$8.1 million (Q2 2025) per Business Quant data.